Device-Aided Therapies in Parkinson's Disease discusses the latest options from a global set of key opinion leaders and emerging specialists using a gender balanced modern and nuanced approach. Sample chapters cover The concept of continuous dopaminergic stimulation, Apomorphine Infusion, LCIG, LECIG, Foslevodopa/Foscarbidopa, ND0612, STN-DBS, Pallidal DBS, MRgFUS, Vestibular Neurostimulation, Patient selection and choice of therapy, The future: Stem cells? Gene therapy?, The future: Trophic factors, and Devices and the dashboard for PD.
1. Chapter One Continuous dopaminergic stimulation and the transition to using continuous drug delivery in Parkinson's disease—An introduction - p. 1 2. Chapter Two Apomorphine infusion in Parkinson's disease: An update - p. 17 3. Chapter Three Levodopa-carbidopa intestinal gel infusion in Parkinson's disease - p. 31 4. Chapter Four Levodopa-entacapone-carbidopa intestinal gel infusion in Parkinson's disease - p. 49 5. Chapter Five Subcutaneous foslevodopa/foscarbidopa: A novel 24 h delivery option for levodopa - p. 63 6. Chapter Six Subthalamic deep brain stimulation surgery for Parkinson's disease - p. 81 7. Chapter Seven Globus pallidus internus deep brain stimulation in the management of movement disorders: Current evidence and future directions - p. 99 8. Chapter Eight Treating Parkinson's disease and movement disorders with transcranial focused ultrasound - p. 147 9. Chapter Nine Patient selection for device aided therapies - p. 169 10. Chapter Ten The future: Stem cells? Current clinical trials using stem cells for dopaminergic cell replacement - p. 191 11. Chapter Eleven The future neurotrophic factor therapy in Parkinson's disease - p. 221
Device-Aided Therapies in Parkinson's Disease discusses the latest options from a global set of key opinion leaders and emerging specialists using a gender balanced modern and nuanced approach. Sample chapters cover The concept of continuous dopaminergic stimulation, Apomorphine Infusion, LCIG, LECIG, Foslevodopa/Foscarbidopa, ND0612, STN-DBS, Pallidal DBS, MRgFUS, Vestibular Neurostimulation, Patient selection and choice of therapy, The future: Stem cells? Gene therapy?, The future: Trophic factors, and Devices and the dashboard for PD.
1. Chapter One Continuous dopaminergic stimulation and the transition to using continuous drug delivery in Parkinson's disease—An introduction - p. 1 2. Chapter Two Apomorphine infusion in Parkinson's disease: An update - p. 17 3. Chapter Three Levodopa-carbidopa intestinal gel infusion in Parkinson's disease - p. 31 4. Chapter Four Levodopa-entacapone-carbidopa intestinal gel infusion in Parkinson's disease - p. 49 5. Chapter Five Subcutaneous foslevodopa/foscarbidopa: A novel 24 h delivery option for levodopa - p. 63 6. Chapter Six Subthalamic deep brain stimulation surgery for Parkinson's disease - p. 81 7. Chapter Seven Globus pallidus internus deep brain stimulation in the management of movement disorders: Current evidence and future directions - p. 99 8. Chapter Eight Treating Parkinson's disease and movement disorders with transcranial focused ultrasound - p. 147 9. Chapter Nine Patient selection for device aided therapies - p. 169 10. Chapter Ten The future: Stem cells? Current clinical trials using stem cells for dopaminergic cell replacement - p. 191 11. Chapter Eleven The future neurotrophic factor therapy in Parkinson's disease - p. 221
